The use of the scientific method as dogma can be an obstacle in times of pandemic
Felipe Inserra, Walter Manucha* and León Ferder
Published: 08 January, 2021 | Volume 5 - Issue 1 | Pages: 001-002
Science is not inherently dogmatic. On the contrary, in our opinion and according to Bachelard, it often breaks with certain dogmas . That is why it must have the necessary flexibility to be able to analyze and incorporate exceptional situations. In this regard, the current Coronavirus pandemic is an exceptional situation causing several thousand deaths a day.
Read Full Article HTML
Cite this Article
Read Full Article PDF
- Bachelard G. La formation de l'esprit scientifique. Paris: Librairie philosophique J. VRIN, 5e édition, 1967. Collection: Bibliothèque des textes philosophiques. 257.
- Soiza RL, Scicluna C, Thomson EC. Efficacy and safety of COVID-19 vaccines in older people. Age Ageing. 2020; afaa274. PubMed: https://pubmed.ncbi.nlm.nih.gov/33320183/
- Eyal N, Lipsitch M, Smith PG. Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure. J Infect Dis. 2020; 221: 1752-1756. PubMed: https://pubmed.ncbi.nlm.nih.gov/32232474/
- Cyranoski D. Why emergency COVID-vaccine approvals pose a dilemma for scientists. Nature. 2020; 588: 18-19. PubMed: https://pubmed.ncbi.nlm.nih.gov/33230275/
- Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy. Health Aff (Millwood). 2021; 40: 42-52. PubMed: https://pubmed.ncbi.nlm.nih.gov/33211536/
- The Lancet. COVID-19 vaccines: no time for complacency. Lancet. 2020; 396: 1607. PubMed: https://pubmed.ncbi.nlm.nih.gov/33220729/
- Mahase E. Covid-19: Vaccine candidate may be more than 90% effective, interim results indicate. BMJ. 2020; 371: m4347. PubMed: https://pubmed.ncbi.nlm.nih.gov/33168562/